Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher B. Ehrlich currently holds 4,530,997 shares of eFFECTOR Therapeutics, Inc. (EFTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher B. Ehrlich has been a net buyer of EFTR stock. They have purchased $13.1M and sold $0 worth of shares.
Christopher B. Ehrlich's most recent insider trade was on Jan 7, 2026, when they sold 4,530,997 shares at $0.00 per share.
Christopher B. Ehrlich serves as Executive at eFFECTOR Therapeutics, Inc. (EFTR). They have executed 45 insider transactions totaling $13.1M over their tenure at the company.
Christopher B. Ehrlich holds the position of Executive at eFFECTOR Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Christopher B. Ehrlich has shown a buying trading pattern, with $13.1M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher B. Ehrlich was on Apr 7, 2009, when they purchased $8.0M worth of BMTI shares. This transaction involved 941,177 shares at $8.50 per share.
Christopher B. Ehrlich currently owns 4,530,997 shares of eFFECTOR Therapeutics, Inc. (EFTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher B. Ehrlich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher B. Ehrlich has 45 Form 4 filings on record as an insider at eFFECTOR Therapeutics, Inc..
Set alerts for Christopher B. Ehrlich and 40,000+ other insiders.